Picture of United Therapeutics logo

UTHR — United Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

United Therapeutics Corp reports results for the quarter ended in June - Earnings Summary

* United Therapeutics Corp  UTHR.OQ  reported quarterly
adjusted
earnings of $5.85​​ per share for the quarter ended in June,
higher than the same quarter last year, when the company
reported EPS of $5.24.  The mean expectation of twelve analysts
for the quarter was for earnings of $6.40 per share. Wall Street
expected results to range from $5.59  to $7.47 per share.
    * Revenue rose 19.8% to $714.90 million from a year ago;
analysts
expected $691.87 million. 
    * United Therapeutics Corp's reported EPS for the quarter
was
$5.85​.
    * The company reported quarterly net income of $278.1
million.
    * United Therapeutics Corp shares had risen by 6.0% this
quarter and gained 53.5% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 3.8%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 10 "strong buy" or "buy," 4
"hold" and 1 "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for United
Therapeutics Corp is $347.00 
This summary was machine generated from LSEG data July 31 at
01:32 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      6.40           5.85           Missed
 Dec. 31 2023      5.65           6.17           Beat
 Dec. 31 2023      4.19           4.36           Beat
 Sep. 30 2023      5.04           5.38           Beat

Recent news on United Therapeutics

See all news